Targeting the Angiotensin Pathway in the Treatment of Cutaneous Fibrosis: A Systematic Review

Targeting the Angiotensin Pathway in the Treatment of Cutaneous Fibrosis: A Systematic Review

Acting on the renin–angiotensin–aldosterone system, angiotensin-converting enzyme inhibitors (ACE-Is) and angiotensin receptor blockers (ARBs) are mechanisms of some of the most prescribed medications in the world. In addition to their routine use for the treatment of hypertension, such agents have...

Full description

Bibliographic Details
Main Authors:	Trenton Greif, Mouaz Alsawas, Alexander T. Reid, Vincent Liu, Larry Prokop, M. Hassan Murad, Jennifer G. Powers
Format:	Article
Language:	English
Published:	Elsevier 2023-11-01
Series:	JID Innovations
Online Access:	http://www.sciencedirect.com/science/article/pii/S2667026723000577

Similar Items

Are these results trustworthy? A guide for reading the medical literature
by: Fares Alahdab, et al.
Published: (2017-04-01)

Sezary syndrome initially presenting as pityriasis rubra pilaris: Clinicopathologic study of 3 cases
by: Mouaz Alsawas, MD, MSc, et al.
Published: (2024-02-01)

Angiotensin II contributes to renal fibrosis independently of Notch pathway activation.
by: Carolina Lavoz, et al.
Published: (2012-01-01)

Insulin augments angiotensin II-induced myocardial fibrosis via the MEK/STAT3 pathway
by: Nanyu Cao, et al.
Published: (2023-12-01)

Cutaneous Manifestations of Cystic Fibrosis
by: Chiriac Anca, et al.
Published: (2018-03-01)

IGF-1 protects against angiotensin II-induced cardiac fibrosis by targeting αSMA
by: Sangmi Ock, et al.
Published: (2021-07-01)

Vitamin D suppresses bleomycin-induced pulmonary fibrosis by targeting the local renin–angiotensin system in the lung
by: Jianjun Chang, et al.
Published: (2021-08-01)

Statins inhibit angiotensin II/Smad pathway and related vascular fibrosis, by a TGF-β-independent process.
by: Raúl Rodrigues Díez, et al.
Published: (2010-01-01)

Ets-1 Targeted by MicroRNA-221 Regulates Angiotensin II-Induced Renal Fibroblast Activation and Fibrosis
by: Jia Di, et al.
Published: (2014-09-01)

Therapeutic effect of renin angiotensin system inhibitors on liver fibrosis
by: Qianqian Zhu, et al.
Published: (2016-02-01)

Role of Nonclassical Renin-angiotensin system Axis In Renal Fibrosis
by: Linli eLv, et al.
Published: (2015-04-01)

Cystic fibrosis: current therapeutic targets and future approaches
by: Misbahuddin M. Rafeeq, et al.
Published: (2017-04-01)

Reduction in skeletal muscle fibrosis of spontaneously hypertensive rats after laceration by microRNA targeting angiotensin II receptor.
by: Roberta Sessa Stilhano, et al.
Published: (2017-01-01)

SIRT3 Deficiency Sensitizes Angiotensin-II-Induced Renal Fibrosis
by: Xiaomeng Feng, et al.
Published: (2020-11-01)

Angiotensin II: a key mediator in the development of liver fibrosis and cancer
by: Sameh Saber
Published: (2018-11-01)

Clusterin/apolipoprotein J attenuates angiotensin II-induced renal fibrosis.
by: Gwon-Soo Jung, et al.
Published: (2014-01-01)

Liver‐Targeted Angiotensin Converting Enzyme 2 Therapy Inhibits Chronic Biliary Fibrosis in Multiple Drug‐Resistant Gene 2‐Knockout Mice
by: Indu G. Rajapaksha, et al.
Published: (2019-12-01)

Pathway2Targets: an open-source pathway-based approach to repurpose therapeutic drugs and prioritize human targets
by: Mauri Dobbs Spendlove, et al.
Published: (2023-09-01)

Targeting Growth Factor and Cytokine Pathways to Treat Idiopathic Pulmonary Fibrosis
by: Hongbo Ma, et al.
Published: (2022-06-01)

Angiotensin II-Induced Cardiovascular Fibrosis Is Attenuated by NO-Sensitive Guanylyl Cyclase1
by: Kathrin Broekmans, et al.
Published: (2020-11-01)

Phosphatidylethanolamine aggravates Angiotensin II-induced atrial fibrosis by triggering ferroptosis in mice
by: Fangze Huang, et al.
Published: (2023-05-01)

Kaempferol Alleviates Angiotensin II-Induced Cardiac Dysfunction and Interstitial Fibrosis in Mice
by: Yuan Liu, et al.
Published: (2017-10-01)

TIGAR deficiency sensitizes angiotensin‐II‐induced renal fibrosis and glomerular injury
by: Xiaochen He, et al.
Published: (2022-04-01)

The Role of IL-6 in Skin Fibrosis and Cutaneous Wound Healing
by: Blair Z. Johnson, et al.
Published: (2020-04-01)

87. Angiotensin II Type 2 Receptor Signal Modulation in Models of Cutaneous Wound Healing
by: Julia M. Harrison, PhD, BScH, et al.
Published: (2023-05-01)

Apelin Inhibits Angiotensin II-Induced Atrial Fibrosis and Atrial Fibrillation via TGF-β1/Smad2/α-SMA Pathway
by: Wenkui Lv, et al.
Published: (2020-11-01)

Healthcare pathway and patients' expectations in pulmonary fibrosis
by: Vincent Cottin, et al.
Published: (2017-04-01)

Renin Angiotensin System (RAS) Pathways in COVID Pathogenesis
by: Sampreeti Mukherjee, et al.
Published: (2023-01-01)

Alternative pathways for angiotensin II generation in the cardiovascular system
by: C. Becari, et al.
Published: (2011-09-01)

Recruitment of macrophages from the spleen contributes to myocardial fibrosis and hypertension induced by angiotensin II
by: Ning-Ping Wang, et al.
Published: (2017-05-01)

Angiotensin II-induced arterial thickening, fibrosis and stiffening involves elevated arginase function.
by: Anil Bhatta, et al.
Published: (2015-01-01)

Angiotensin-converting-enzyme inhibitor prevents skeletal muscle fibrosis in myocardial infarction mice
by: Naoya Kakutani, et al.
Published: (2020-04-01)

The promise of mTOR as a therapeutic target pathway in idiopathic pulmonary fibrosis
by: Manuela Platé, et al.
Published: (2020-10-01)

Advances in Targeting Cutaneous Melanoma
by: Dimitri Kasakovski, et al.
Published: (2021-04-01)

Signaling pathways in cutaneous wound healing
by: Olga Krizanova, et al.
Published: (2022-11-01)

Angiotensin II type 1 and 2 receptors and lymphatic vessels modulate lung remodeling and fibrosis in systemic sclerosis and idiopathic pulmonary fibrosis
by: Edwin Roger Parra, et al.
Published: (2014-01-01)

Angiotensin Converting Enzyme‐2 Therapy Improves Liver Fibrosis and Glycemic Control in Diabetic Mice With Fatty Liver
by: Indu G. Rajapaksha, et al.
Published: (2022-05-01)

Targeting Renin–Angiotensin System Against Alzheimer’s Disease
by: Abadi Kahsu Gebre, et al.
Published: (2018-04-01)

Therapeutic targets of renin-angiotensin system in ocular disorders
by: Rajesh Choudhary, et al.
Published: (2017-03-01)

Irisin attenuates angiotensin II-induced atrial fibrillation and atrial fibrosis via LOXL2 and TGFβ1/Smad2/3 signaling pathways
by: Yingbiao Wu, et al.
Published: (2023-06-01)